跳到正文
原文
NICE· @NICEComms · X·· 5 天前精选AI 评分58
AI 导读

NICE 推荐了一款新的延长生存期治疗药物,用于晚期肛癌,即日起可在 NHS 使用,约250名患者可能受益。这是 NICE 针对该特定类型肛癌推荐的首款药物。

推荐理由

NICE 推荐首个针对该特定类型肛癌的药物,读者可了解这一患者群体的新治疗选择及覆盖人数。

正文

Around 250 people with advanced anal cancer could benefit from a new life-extending treatment recommended by NICE and available on the NHS from today.

It’s the first NICE-recommended drug for this specific form of anal cancer.

Read more: https://orlo.uk/0OsZd

来源:NICE · x.com